Literature DB >> 32632239

T cell antigen discovery.

Alok V Joglekar1,2,3, Guideng Li4,5,6.   

Abstract

T cells respond to threats in an antigen-specific manner using T cell receptors (TCRs) that recognize short peptide antigens presented on major histocompatibility complex (MHC) proteins. The TCR-peptide-MHC interaction mediated between a T cell and its target cell dictates its function and thereby influences its role in disease. A lack of approaches for antigen discovery has limited the fundamental understanding of the antigenic landscape of the overall T cell response. Recent advances in high-throughput sequencing, mass cytometry, microfluidics and computational biology have led to a surge in approaches to address the challenge of T cell antigen discovery. Here, we summarize the scope of this challenge, discuss in depth the recent exciting work and highlight the outstanding questions and remaining technical hurdles in this field.

Year:  2020        PMID: 32632239     DOI: 10.1038/s41592-020-0867-z

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  108 in total

Review 1.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

Review 2.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 3.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

Review 4.  Understanding the drivers of MHC restriction of T cell receptors.

Authors:  Nicole L La Gruta; Stephanie Gras; Stephen R Daley; Paul G Thomas; Jamie Rossjohn
Journal:  Nat Rev Immunol       Date:  2018-07       Impact factor: 53.106

Review 5.  Codification of bidentate pMHC interaction with TCR and its co-receptor.

Authors:  Ellis L Reinherz; Jia-huai Wang
Journal:  Trends Immunol       Date:  2015-03-26       Impact factor: 16.687

Review 6.  Unconventional T Cell Targets for Cancer Immunotherapy.

Authors:  Dale I Godfrey; Jérôme Le Nours; Daniel M Andrews; Adam P Uldrich; Jamie Rossjohn
Journal:  Immunity       Date:  2018-03-20       Impact factor: 31.745

Review 7.  The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy.

Authors:  Richard D Paucek; David Baltimore; Guideng Li
Journal:  Trends Immunol       Date:  2019-03-11       Impact factor: 16.687

Review 8.  Present Yourself! By MHC Class I and MHC Class II Molecules.

Authors:  Kenneth L Rock; Eric Reits; Jacques Neefjes
Journal:  Trends Immunol       Date:  2016-09-07       Impact factor: 16.687

Review 9.  The many important facets of T-cell repertoire diversity.

Authors:  Janko Nikolich-Zugich; Mark K Slifka; Ilhem Messaoudi
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

Review 10.  Why must T cells be cross-reactive?

Authors:  Andrew K Sewell
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

View more
  20 in total

1.  PD-1 preferentially inhibits the activation of low-affinity T cells.

Authors:  Kenji Shimizu; Daisuke Sugiura; Il-Mi Okazaki; Takumi Maruhashi; Tatsuya Takemoto; Taku Okazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-31       Impact factor: 11.205

Review 2.  TCR-sequencing in cancer and autoimmunity: barcodes and beyond.

Authors:  Kristen E Pauken; Kaitlyn A Lagattuta; Benjamin Y Lu; Liliana E Lucca; Adil I Daud; David A Hafler; Harriet M Kluger; Soumya Raychaudhuri; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2022-01-25       Impact factor: 16.687

3.  Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens.

Authors:  Paul R Buckley; Chloe H Lee; Ruichong Ma; Isaac Woodhouse; Jeongmin Woo; Vasily O Tsvetkov; Dmitrii S Shcherbinin; Agne Antanaviciute; Mikhail Shughay; Margarida Rei; Alison Simmons; Hashem Koohy
Journal:  Brief Bioinform       Date:  2022-05-13       Impact factor: 13.994

Review 4.  Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy.

Authors:  Ahmed Halima; Winston Vuong; Timothy A Chan
Journal:  J Clin Invest       Date:  2022-06-15       Impact factor: 19.456

5.  3pHLA-score improves structure-based peptide-HLA binding affinity prediction.

Authors:  Anja Conev; Didier Devaurs; Mauricio Menegatti Rigo; Dinler Amaral Antunes; Lydia E Kavraki
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

Review 6.  Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease.

Authors:  Aaron M Rosenberg; Brian M Baker
Journal:  Curr Opin Struct Biol       Date:  2022-03-25       Impact factor: 7.786

7.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

Review 8.  High-throughput and single-cell T cell receptor sequencing technologies.

Authors:  Joy A Pai; Ansuman T Satpathy
Journal:  Nat Methods       Date:  2021-07-19       Impact factor: 47.990

Review 9.  Methods for sequence and structural analysis of B and T cell receptor repertoires.

Authors:  Shunsuke Teraguchi; Dianita S Saputri; Mara Anais Llamas-Covarrubias; Ana Davila; Diego Diez; Sedat Aybars Nazlica; John Rozewicki; Hendra S Ismanto; Jan Wilamowski; Jiaqi Xie; Zichang Xu; Martin de Jesus Loza-Lopez; Floris J van Eerden; Songling Li; Daron M Standley
Journal:  Comput Struct Biotechnol J       Date:  2020-07-17       Impact factor: 7.271

10.  An Effective COVID-19 Vaccine Needs to Engage T Cells.

Authors:  Karsten Sauer; Tim Harris
Journal:  Front Immunol       Date:  2020-09-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.